Altamira Therapeutics

Swiss pharmaceutical firm Altamira Therapeutics Ltd (NASDAQ: CYTO) and its Chinese partner Nuance Pharma have announced an expansion of their licensing agreement for the anti-rhinitis spray Bentrio. The agreement extends the product’s reach to include Singapore, Malaysia, Thailand, the Philippines, Indonesia, Vietnam, and Taiwan, complementing the existing markets of China,…